Kymera Therapeutics, Inc.
USD115.77
+1.78 (+1.56%)
CEO
Nello Mainolfi
IPO Date
2020-08-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$110.41
Prev. Close
$113.99
Day Low
$110.41
Day High
$117.00
52W Low
$36.65
52W High
$130.05
Market Cap
$9.52B
Volume
0.72M
| 50,000 |
| $119.00 |
| 7 Jul 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | M-Exempt | Disposed | 45,559 | $2.08 |
| 7 Jul 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | M-Exempt | Disposed | 4,441 | $2.08 |
| 2 Jul 2026 | Jacobs Bruce N. | Chief Financial Officer | M-Exempt | Acquired | 61,378 | $5.33 |
| 2 Jul 2026 | Jacobs Bruce N. | Chief Financial Officer | S-Sale | Disposed | 1,500 | $110.54 |
| 2 Jul 2026 | Jacobs Bruce N. | Chief Financial Officer | S-Sale | Disposed | 1,700 | $111.57 |
| 2 Jul 2026 | Jacobs Bruce N. | Chief Financial Officer | S-Sale | Disposed | 1,100 | $112.79 |
| 2 Jul 2026 | Jacobs Bruce N. | Chief Financial Officer | S-Sale | Disposed | 4,110 | $114.19 |
| 2 Jul 2026 | Jacobs Bruce N. | Chief Financial Officer | S-Sale | Disposed | 51,375 | $114.77 |